Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
About this item
Full title
Author / Creator
Wu, Yuze , Yi, Ming , Niu, Mengke , Mei, Qi and Wu, Kongming
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The clinical responses observed following treatment with immune checkpoint inhibitors (ICIs) support immunotherapy as a potential anticancer treatment. However, a large proportion of patients cannot benefit from it due to resistance or relapse, which is most likely attributable to the multiple immunosuppressive cells in the tumor microenvironment (...
Alternative Titles
Full title
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d7af662eb0644094891aa0f0c567beeb
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d7af662eb0644094891aa0f0c567beeb
Other Identifiers
ISSN
1476-4598
E-ISSN
1476-4598
DOI
10.1186/s12943-022-01657-y
